The paper's citation list
No.The paper's citation list
1siRNAs Targeting Growth Factor Receptor and Anti-Apoptotic Genes Synergistically Kill Breast Cancer Cells through Inhibition of MAPK and PI-3 Kinase Pathways. 2018;6:73 doi: 10.3390/biomedicines6030073
2Metformin in Lung Cancer: Review of in Vitro and in Vivo Animal Studies. 2017;9:45 doi: 10.3390/cancers9050045
3Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance. 2018;33:1 doi: 10.1080/14756366.2017.1370583
4BCOR Alterations in Pediatric and Young Adult Patients With Sarcomas and High-Grade Glial Malignancies: A Case Series. 2019;1 doi: 10.1200/PO.19.00116
5Steering the antitumor drug discovery campaign towards structurally diverse indolines. 2020;94:103436 doi: 10.1016/j.bioorg.2019.103436
6Oncogenic Signaling in Tumorigenesis and Applications of siRNA Nanotherapeutics in Breast Cancer. 2019;11:632 doi: 10.3390/cancers11050632
7Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential. 2019;9:174 doi: 10.3390/biom9050174
8VEGF-and EGF-mediated cooperation of eosinophilic granulocytes and tumor cells in gastric and colon cancer. 2019;18:211 doi: 10.20538/1682-0363-2019-1-211-219
9Cyclic RGD-Conjugated Hyaluronate Dot Bearing Cleavable Doxorubicin for Multivalent Tumor Targeting. 2020; doi: 10.1021/acs.biomac.0c00554
10A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma. 2017;12:e0183969 doi: 10.1371/journal.pone.0183969